Stata

New Stata 18 Statistical Software Empowers Researchers to Make the Most Out of Their Analyses

Retrieved on: 
Wednesday, April 26, 2023
Professional Services, Data Management, Data Analytics, Technology, Software, Research, Science, Data management, DID, Workflow, Data science, Statistics, Public policy, Software design, History, Meta-analysis, Policy, Biostatistics, Economics, Information technology, Risk management, Management, Stata, List of things named after Thomas Bayes

StataCorp, a leading developer of software for data science, announced the newest version of its software: Stata 18.

Key Points: 
  • StataCorp, a leading developer of software for data science, announced the newest version of its software: Stata 18.
  • Stata 18 is the latest in StataCorp's almost 40-year history of providing powerful solutions for data manipulation, visualization, statistics, and automated reporting.
  • "We designed Stata 18 to be intuitive for users so that it enhances their workflow," said Chinh Nguyen, Vice President of Software Design.
  • Stata 18 introduces many new statistical features.

Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer

Retrieved on: 
Tuesday, September 13, 2022
Safety, NYSE, FDA, Disease, ANN, Talazoparib, Melanoma, Patient, Stata, Cancer, Axitinib, PFE, RNA, MRD, DNA, Neoplasm, Angiogenesis, Pharmaceutical industry, Medical imaging, Stratum, Pfizer

ANN ARBOR, Mich., Sept. 13, 2022 /PRNewswire/ -- Strata Oncology, Inc. a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced expansion of its clinical collaboration with Pfizer (NYSE: PFE) in the Strata Precision Indications for Approved THerapies (Strata PATHTM) trial. Strata PATH is a prospective pan-tumor therapeutic trial designed to evaluate the efficacy and safety of multiple FDA-approved cancer therapies in new, biomarker-guided patient populations. Pfizer will provide Braftovi® (encorafenib), Mektovi® (binimetinib), and Lorbrena® (lorlatinib) for up to six new cohorts of patients with early-stage lung, melanoma, colorectal, and other cancers who have evidence of micrometastatic disease after initial treatment. Pfizer is already providing Strata with Braftovi® (encorafenib), Mektovi® (binimetinib), Lorbrena® (lorlatinib), Talzenna® (talazoparib), and Inlyta (axitinib) for evaluation in four late-stage cohorts of the Strata PATH trial.

Key Points: 
  • a next-generation precision oncology company enabling smarter and earlier cancer treatment, today announced expansion of its clinical collaboration with Pfizer (NYSE: PFE) in the Strata Precision Indications for Approved THerapies (Strata PATHTM) trial.
  • Strata PATH is a prospective pan-tumor therapeutic trial designed to evaluate the efficacy and safety of multiple FDA-approved cancer therapies in new, biomarker-guided patient populations.
  • Pfizer is already providing Strata with Braftovi (encorafenib), Mektovi(binimetinib), Lorbrena (lorlatinib), Talzenna (talazoparib), and Inlyta (axitinib) for evaluation in four late-stage cohorts of the Strata PATH trial.
  • Strata Oncology, Inc. is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer.

Vincent Roche to Succeed Ray Stata as Chair of Analog Devices in 2022

Retrieved on: 
Wednesday, January 19, 2022
Semiconductor, Engineering, Automotive Manufacturing, Technology, Manufacturing, Hardware, Analog Devices, Board of directors, ADI, Annual general meeting, NASDAQ, CEO, Roche, Massachusetts Institute of Technology, Leadership, History, Nasdaq, Company, Device, MIT, Chairperson, Chair, Board, Stata, Management

Analog Devices , Inc. (NASDAQ: ADI) today announced that its Board of Directors has appointed President and CEO Vincent Roche as Chair of the Board, effective as of the date of ADIs 2022 Annual Meeting of Shareholders.

Key Points: 
  • Analog Devices , Inc. (NASDAQ: ADI) today announced that its Board of Directors has appointed President and CEO Vincent Roche as Chair of the Board, effective as of the date of ADIs 2022 Annual Meeting of Shareholders.
  • Roche will succeed Ray Stata, who has served as Chair of the Board since 1973 and will become only the second Chair in ADIs history.
  • Stata will stand for reelection as a director at ADIs 2022 Annual Meeting of Shareholders.
  • ADI has grown exponentially over the five decades that Ray has served as Chair, and I am honored to be appointed as his successor, said Roche.

StataCorp Moves to a 32-hour Workweek to Better Support Employee Health, Satisfaction, and Productivity

Retrieved on: 
Thursday, July 1, 2021
Professional services, Data management, Technology, Human resources, Software, Research, Science, Labor, Articles, Economy, Labor history, Working time, Human resource management, Labor rights, Industrial and organizational psychology, Flextime, Stata, Productivity, Workweek and weekend

StataCorp announced today it will move to a flexible work schedule designed to promote better work-life balance for its employees.

Key Points: 
  • StataCorp announced today it will move to a flexible work schedule designed to promote better work-life balance for its employees.
  • Founded in 1983 with headquarters in College Station, TX, StataCorp produces the statistics and data science software Stata.
  • StataCorp is redefining its full-time workweek for all employees, reducing the standard 40 hours to 32.
  • It is confident that a better work-life balance will increase both employee satisfaction and productivity.

Groundbreaking Educational Video Conferencing Platform InSpace Raises $6M in Seed Funding

Retrieved on: 
Tuesday, June 8, 2021
Econometrics software, Stata, Statistics, Computational statistics, Mathematical software

BURLINGTON, Vt., June 8, 2021 /PRNewswire/ -- InSpace ,a collaborative video conferencing platform that replicates personal interaction between students and teachers in virtual classrooms, today announcedthat the company has closed on $6 million in two rounds of seed funding.

Key Points: 
  • BURLINGTON, Vt., June 8, 2021 /PRNewswire/ -- InSpace ,a collaborative video conferencing platform that replicates personal interaction between students and teachers in virtual classrooms, today announcedthat the company has closed on $6 million in two rounds of seed funding.
  • The seed funding will expand educator support to keep pace with rapid growth and establish a resource network for users to share ideas and successes.
  • Created by educators for educators, InSpace is used by thousands of professors in over 100 universities and K-12 schools worldwide.
  • "We utilized the InSpace platform for our very first video conference and we were just blown away," said Nicole Stata, general partner, Boston Seed Capital.

StataCorp Contributes Data Science Software to COVID-19 Research Database for Academic and Medical Research

Retrieved on: 
Tuesday, July 7, 2020
Econometrics software, Statistics, Stata, Software, Science software, Raymie Stata

Researchers accessing the large, diverse repository of real-world data will be provided access to StataCorp's data science software Stata pro bono to facilitate their analysis in the database environment.

Key Points: 
  • Researchers accessing the large, diverse repository of real-world data will be provided access to StataCorp's data science software Stata pro bono to facilitate their analysis in the database environment.
  • Since launching in April, more than 1000 researchers have registered for the database from more than 350 academic institutions.
  • For over 30 years, StataCorp has been a leader in statistical and data science software.
  • Stata provides everything for research professionals' data science needs--data manipulation, visualization, statistics, and reproducible reporting.

StataCorp Launches Stata Release 16

Retrieved on: 
Tuesday, July 9, 2019
Data management, Technology, Other Technology, Other Science, Research, Software, Internet, Science, Programming languages, Computer languages, Econometrics software, Stata, Cross-platform software, Lasso

This latest release will not only delight Stata's core users but also entice other data scientists to take a fresh look at Stata.

Key Points: 
  • This latest release will not only delight Stata's core users but also entice other data scientists to take a fresh look at Stata.
  • Bill Gould, President of StataCorp and Head of Development, said about the release, "This release posed challenges like we have never seen.
  • Stata 16 adds lasso models as Stata introduces its first official suite of commands for machine learning.
  • Stata's core user camps will be pleased that release 16 incorporates a complete suite of meta-analysis features.

Massachusetts High Technology Council Holds 2019 Annual Meeting

Retrieved on: 
Friday, June 14, 2019
Regions of the United States, Ray Stata, Greater Boston, Massachusetts Institute of Technology, Stata, Lowell, Massachusetts, Charlie Baker, Boston, Massachusetts, Analog Devices, Raymie Stata

BURLINGTON, Mass., June 14, 2019 /PRNewswire/ --Before an audience of 200 technology and civic leaders at Boston's Seaport Hotel, the Massachusetts High Technology Council honored University of Massachusetts at Lowell Chancellor Jacqueline Moloney with its Ray Stata Leadership and Innovation Award, and hosted Governor Charlie Baker and Congressman Joseph P. Kennedy, III at its 2019 Annual Meeting on June 10.

Key Points: 
  • BURLINGTON, Mass., June 14, 2019 /PRNewswire/ --Before an audience of 200 technology and civic leaders at Boston's Seaport Hotel, the Massachusetts High Technology Council honored University of Massachusetts at Lowell Chancellor Jacqueline Moloney with its Ray Stata Leadership and Innovation Award, and hosted Governor Charlie Baker and Congressman Joseph P. Kennedy, III at its 2019 Annual Meeting on June 10.
  • The Council's annual meeting is the Commonwealth's premier forum for leaders from business, government, and academia to convene, collaborate and advance initiatives that drive research, innovation, and the region's technology economy.
  • The Stata Award was created by the Council in 2017 and is awarded from time to time to a technology leader who is currently active in Massachusetts and exhibits the key leadership qualities and commitment to philanthropy and civic engagement possessed and demonstrated by Massachusetts technology pioneer Ray Stata, the founder of Analog Devices and a co-founder of the High Tech Council.
  • Our mission is simple: to help make Massachusetts the world's most attractive place in which to live and work, and in which to create, operate, and grow high technology businesses.

Movellus Raises $6M in Series A Funding, Led by Stata Venture Partners

Retrieved on: 
Monday, April 1, 2019
Technology, Hardware, Internet, Software, Semiconductor, Economy, Ray Stata, Finance, Analog Devices, Financial markets, Stata, Venture capital, Raymie Stata

Movellus, Inc. today announced $6 million in Series A venture funding, bringing its total funding to date to $10M.

Key Points: 
  • Movellus, Inc. today announced $6 million in Series A venture funding, bringing its total funding to date to $10M.
  • The $6 million in funding was led by Stata Venture Partners, run by Ray Stata, founder and Chairman of Analog Devices.
  • Movellus innovative approach of leveraging digital design infrastructure and their proprietary architectures to implement analog blocks is poised to have a major impact on the semiconductor industry,stated Ray Stata, Founder, Stata Venture Partners.
  • It is an honor to work with Stata Venture Partners to accelerate our growth and transform how traditional analog design is implemented in SoCs.